Sensor CDT Industry Lecture: Daniel Craig from AstraZeneca

Add to your list(s) Download to your calendar using vCal

• Daniel Craig, AstraZeneca
• Thursday 15 April 2021, 13:30-15:00
• Zoom.

If you have a question about this talk, please contact Suzanne Boone.

Title: Learnings from Biopharmaceutical Technology Transfer

Bio: Dr Daniel Craig as Senior Scientist leading the Process Development group in the Flu-BPD department of the Biopharmaceutical Development division of AstraZeneca. He holds a PhD in Biochemistry from the University of Leicester for studies into the structure and mechanism of redox enzymes and a Bachelors of Science (Honours) from the University of Edinburgh. After working as a post-doc for Professor Steve Chapman at the University of Edinburgh he spent twelve years at Fujifilm Diosynth Biotechnologies near Middlesbrough, two years at Biogen’s Hillerød site and two years at Ipsen Biopharm’s Wrexham site before joining AstraZeneca. His roles at Fujifilm Diosynth Biotechnologies, Biogen and Ipsen Biopharm were focused on the technology transfer, development and scale-up of therapeutic proteins from E. coli, yeast and cell culture.

This talk is part of the Sensors CDT seminars series.

This talk is included in these lists:

• All Talks (aka the CURE list)
• CamBridgeSens
• Cambridge talks
• Chemical Engineering and Biotechnology
• Featured lists
• ME Seminar
• School of Technology
• Sensors CDT seminars
• Trust & Technology Initiative - interesting events
• Zoom

Note that ex-directory lists are not shown.